| 伊班膦酸钠联合治疗类固醇性骨质疏松症26例临床观察 |
| |
| 引用本文： | 黄松,冯栋.伊班膦酸钠联合治疗类固醇性骨质疏松症26例临床观察[J].中国实用医药,2011,6(20):7-8. |
| |
| 作者姓名： | 黄松 冯栋 |
| |
| 作者单位： | 1. 广西医科大学第一附属医院内分泌科,530021
2. 广西浦北县人民医院内分泌科 |
| |
| 摘 要： | 目的 探讨伊班膦酸钠联合碳酸钙D3片及骨化三醇胶丸治疗类固醇性骨质疏松症的安全性及疗效.方法 对26例类固醇性骨质疏松症患者进行前后自身对照研究.患者年龄31～76(平均52±4.6)岁,口服碳酸钙D3片0.6 g/d,骨化三醇胶丸0.25 μg,每隔3个月静脉滴注伊班磷酸钠2 mg,总疗程l2个月,对比治疗前后的骨密度变化.结果 治疗12个月后,患者腰椎、股骨颈、大转子及Ward's三角骨密度显著增加(均P<0.05),增幅分别达6.5%、4.3%、3.8%及3.2%.结论 伊班磷酸钠联合碳酸钙D3片及骨化三醇胶丸治疗类固醇性骨质疏松症安全、有效、方便.
|
| 关 键 词： | 骨质疏松症 伊班膦酸钠 碳酸钙 骨化三醇 治疗 |
Clinical Observations of Ibandronate Combined with Calcium Carbonate D3 and Calcitriol in 26 Patients with Glucocorticoid-induced Osteoporosis |
| |
| HUANG Song,FENG Dong.Clinical Observations of Ibandronate Combined with Calcium Carbonate D3 and Calcitriol in 26 Patients with Glucocorticoid-induced Osteoporosis[J].China Practical Medical,2011,6(20):7-8. |
| |
| Authors: | HUANG Song FENG Dong |
| |
| Institution: | HUANG Song,FENG Dong.Department of Endocrinology,The First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China,Department of Endocrinology,PuBeiXian people's hospital,PuBei,535300,Guangxi |
| |
| Abstract: | Objective To observe the safety and effects of Ibandronate combined with Calcium carbonate D3 and Calcitriol in patients with Glucocorticoid-induced osteoporosis.Methods 26 patients with Glucocorticoid-induced osteoporosis,aged 31~76 years old,took Calcium carbonate D3 0.6 g/d and calcitriol 0.25ug/d,and then received ibandronate 2 mg per 3 months for 12 months.Bone mineral density(BMD)were measured and compared before and after treatment.Results After 12 months of treatment BMD at lumbar,neck,torch and War... |
| |
| Keywords: | Osteoporosis Ibandronate Calcium Calcitriol Treatment |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
